Eruslanov E, Stoff T, Kim W-J, Daurkin I, Algood C, Gilbert SM, Su L-M, Vieweg J, Daaka Y, Kusmartsev S. Expansion of inflammatory CCR8+ myeloid cells in patients with renal and urothelial carcinomas. Under revision, Clinical Cancer Research.
Kusmartsev S. Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the cancer inflammation and immune suppression. Oncoimmunology, 2012 (e-pub ahead of print)
Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, C. Algood, Gilbert SM, Rosser CJ, Su L.M, Vieweg J, Kusmartsev S. Tumor-associated macrophages mediate immune suppression in kidney cancer microenviroment by activating 15-lipoxygenase pathway. Cancer Research, 2011, 71(20):6400-9.
Eruslanov E, McCullers M, Daurkin I, Algood C, Dahm P, Rosser CJ, Vieweg J, Gilbert SM, Kusmartsev S. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer in patients. International Journal of Cancer, 2011(e-pub ahead of print).
Eruslanov E, Daurkin I, Vieweg J, Daaka Y, Kusmartsev S. AbberantPGE(2) metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells. International Immunopharmacology, 2011(e-pub ahead of print).
Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S. Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells. Pivotal Advance: Journal of Leukocyte Biology, 2010, 88(5):839-48.
Daurkin I, Eruslanov E, Vieweg J, Kusmartsev S. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine. Cancer Immunology Immunotherapy, 2010, 59(5):697-706.
Kaliberova L, Kusmartsev S, Stockard C.R., Krendelshikova V, Griszzle W.E, Buchsbaum DJ. Kaliberov S. Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression. Molecular Cancer Therapeutics, 2009, 8(11):3130-9.
Vieweg J and Kusmartsev S. Enhancing efficacy of cancer vaccines in urologic oncology: new directions. Nature Reviews Urology, 2009, 6(10): 540-549.
Sakamoto N, Porvasnik S, Kusmartsev S, Eruslanov E, Cao W, Urbanek C, Rosser CJ. CXCR4 inhibitor delays growth of human prostate xenografts. The Prostate, 2009, 69 (13):1460-69.
Eruslanov E, Kaliberov S, Daurkina I, Kaliberova L, Buchsbaum D, Vieweg J, Kusmartsev S. Altered expression of 15-PGDH in intra-tumoral CD11b myeloid cells: a mechanism for immune evasion in cancer. J. Immunology, 2009, 182(12):7548-57.
CorzoC, Cheng P, CotterMJ, KusmartsevS, SotomayorE, PadhyaT, McCaffreyTV, McCaffrey JC, GabrilovichDI.Mechanism regulating reactive oxygen in myeloid-derived suppressor cells in cancer. J. Immunology, 2009, 182: 5693-5701.
Sakai Y., Goodison S., Kusmartsev S, Fletcher B, Eruslanov E., Cao W, Porvasnik S, Namiki K, Anai S, RosserC.J. Bcl-2 modulates angiogenesis and lymphangiogenesis in prostate xenografts. The Prostate, 2009, 1:69(5):459-70.
Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Coleman D, Dahm P, Vieweg. J. Reversal of myeloid cell-mediated tumor-associated immune suppression in patients with metastatic renal cell carcinoma. Clinical Cancer Research, 2008, 14(24):8270-8.
Kusmartsev S, Eruslanov E., Kubler H., S Sakai Y, Su Z, Rosser C., Dahm P, Siemann D, Vieweg. Oxidative stress up-regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. Journal of Immunology, 2008, 181(1):346-53.
Vieweg J, Su Z, Dahm P, Kusmartsev S. Reversal of tumor-mediated immune suppression (Review). Clinical Cancer Research, 2007, 13(2):727-732.
Kusmartsev S and Gabrilovich D. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer (Review). Cancer and Metastases Reviews, 2006, 25(3):323-31.
Kusmartsev S and Gabrilovich D. Role of immature myeloid cells in immune evasion mechanisms in cancer (Review). Cancer Immunology and Immunotherapy, 2006, 55(3):237-245.
Kusmartsev S, S. Nagaraj and D Gabrilovich. Mechanism of tumor-associated CD8+ T cell tolerance induced by bone marrow derived immature myeloid cells. Journal of Immunology, 2005, 175(7):4583-92.
Kusmartsev Sand DI Gabrilovich. Critical role of Stat1 signaling in T cell deletion mediated by tumor-associated macrophages. Journal of Immunology, 2005, V.174 (8) p. 4880-4991.
Nefedova Y, M. Huang, S. Kusmartsev, R. Bhattachary, P. Cheng, R. Salup, R. Jove and DI Gabrilovich. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. Journal of Immunology, 2004, 172(1): 464-74
Kusmartsev S, Y. Nefedova, D. Yoder and DI Gabrilovich. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology, 2004, 172 (2): 989-999
Kusmartsev S, F.Cheng, B. Yu, Y. Nefedova, E. Sotomayor and DI Gabrilovich. All-trans-retinoic acid (ATRA) reduces number of immature myeloid cells and improves vaccination against tumor. Cancer Research, 2003, 63: 4441-4449.
Kusmartsev S and DI Gabrilovich. Inhibition of myeloid cell differentiation in cancer: role of reactive oxygen species. Journal of Leukocyte Biology, 2003, 74 (2): 186-196
Yu B,S. Kusmartsev,F. Cheng, Y. Nefedova, E. Sotomayor and DI Gabrilovich. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced stage experimental breast cancer. Clinical Cancer Research, 2003, 9(1): 285-294.
Kusmartsev S. and DI Gabrilovich. Immature myeloid cells and cancer-induced immune suppression (Review). Cancer Immunology and Immunotherapy, 2002, 51(6): 293-298. Review.
Kusmartsev S. and DI Gabrilovich. Evaluation of T cell immune responses in cancer patients. Chapter in review: Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J Immunotherapy, 2002, 25(2): 97-104.
Kusmartsev S.A.,Y. Li andS.-H. Chen. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. Journal of Immunology, 2000, 165: 779-785.
Kusmartsev SA, JMG Ruiz de Morales,J. Rullas, M. Danilets and J.L. Subiza. Sialoadhesin expression by bone marrow macrophages derived from Ehrlich tumor-bearing mice. Cancer Immunology and Immunotherapy, 1999, 48: 493-498.
Kusmartsev SA, IN Kusmartseva, S.G. Afanasyev and N.V. Cherdyntseva. Functional characteristic of immune suppressive cells in bone marrow of cancer patients. International Journal of Imunopathology and Pharmacology, 1998, 11 (3): 171-178
Bel’skii YuP, MG Danilets, NV Bel’skaya, ES Stal’bovskaya and SA Kusmartsev (1999). Role of interferon-gamma in regulation of anti-proliferative activity of bone marrow non-adherent cells. Bull. Experimental Biol. and Med. (Moscow), 128 (12): 677-680.
Goldberg ED, YP. Bel’skii, MG. Danilets, A.M. Dygai, S. Kosnireva, SA Kusmartsev and I.A Khlusov (1998). Changes in structural and functional organization of the bone marrow during aging of AKR/J mice. Bull. Experimental Biol. and Med., 125 (3): 266-269.
Cherdyntseva NV, OA Polushina, SA Kusmartsev and NV Vasilyev (1997). Comparative analysis of cytostatic and membrane-toxic activity of tumor-associated lymphocytes. Immunologia (Moscow), 3: 55-58.
Dygai AM, Zhdanov VV, Khlusov IA, Lyubavina, PA Novitskii, SA Kusmartsev, Goldberg E.D. (1997). Glycyrram stimulates bone marrow hematopoiesis under cytostatic myelosuppression. Russian Journal of Experimental and Clinical Pharmacology, 1 (1): 78-80.
Limareva TD, VM Plotnikov, SA Kusmartsev, GF Ermakov and NV Zemlianskaya (1995). Synthesis and study of immunotoxins based on the phospholypase C bacterial toxin. Immunologia, 5: 60-63.
Kusmartsev SA, YP Bel’skii, IM Agranovich and NV Zemlianskaya (1994). The natural suppressor cells (Review). Advances in Current Biology (Moscow), 114 (6): 706-714. Review.
IV. BOOKS AND CHAPTERS IN BOOKS
Eruslanov E. and Kusmartsev S. Identification of ROS using oxidized DCFDA and flow cytometry. Methods Mol Biol. 2010;594:57-72.
Bel’skii YuP, Cherdyntseva N.V., Agafonov V.I., Kusmartsev S. Natural suppressor cells in disease (in Russian), 2006, Tomsk, Tomsk State University.
Cherdyntseva NV, S. Kusmartsev and DI Gabrilovich. Polymorphonuclear neutrophils and cancer: ambivalent role in host defense against tumor. Chapter in book: “The neutrophils: new outlook on old cells”, 2005, Imperial College Press, London, UK, p.275-97.
